Exhibit 16.1
August 29, 2024
Securities and Exchange Commission
100 F Street, NE
Washington, DC 20549
Dear Ladies and Gentlemen:
We have read the statements made by Entero Therapeutics, Inc. (the “Company”) (copy attached), which we understand will be filed with the Securities and Exchange Commission pursuant to Item 4.01 of Form 8-K, as part of the Form 8-K dated August 29, 2024. We agree with the statements concerning our Firm in such Form 8-K.
We have no basis to agree or disagree with other statements made under Item 4.01.
Sincerely,
/s/ Macias Gini & O’Connell LLP
Melville, New York
1